These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34251034)

  • 1. Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Chidambaram V; Jones JM; Lokhandwala PM; Bloch EM; Lanzkron S; Stewart R; Pecker LH
    Transfusion; 2021 Aug; 61(8):2421-2429. PubMed ID: 34251034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of transfusion-transmissible infections among blood donors at National Blood Transfusion Service, Eritrea: a seven-year retrospective study.
    Siraj N; Achila OO; Issac J; Menghisteab E; Hailemariam M; Hagos S; Gebremeskel Y; Tesfamichael D
    BMC Infect Dis; 2018 Jun; 18(1):264. PubMed ID: 29879912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
    Ogbenna AA; Akinsete AM; Kalejaiye OO; Matthew OK; Sharma D; Andrews J; Kassim AA
    Br J Haematol; 2022 Aug; 198(4):745-752. PubMed ID: 35719004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major risk of blood transfusion in hemolytic anemia patients.
    Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence and trends in transfusion transmissible infections among voluntary non-remunerated blood donors at the Malawi Blood Transfusion Service-a time trend study.
    M'baya B; Jumbe V; Samuel V; M'bwana R; Mangani C
    Malawi Med J; 2019 Jun; 31(2):118-125. PubMed ID: 31452844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study.
    Grubyte S; Urboniene J; Nedzinskiene L; Jelinskaite A; Zagminas K; Ambrozaitis A; Jancoriene L
    PLoS One; 2021; 16(2):e0246704. PubMed ID: 33606700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of transfusion transmissible infections among patients with sickle cell disease in Nigeria: case-control study.
    Akpa O; Babalola O; Odetunde A; Fagbamigbe A; Fasola F; Brown B; Alamukii N; Babalola C; Odaibo G; Falusi A
    J Immunoassay Immunochem; 2022 Jul; 43(4):435-451. PubMed ID: 35285420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.
    Kim MJ; Park Q; Min HK; Kim HO
    BMC Infect Dis; 2012 Jul; 12():160. PubMed ID: 22817275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
    Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
    Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human immunodeficiency virus, hepatitis C virus and hepatitis B viruses in patients with sickle-cell disease in Togo].
    Ségbéna AY; Prince-David M; Kagoné TS; Dagnra AY
    Transfus Clin Biol; 2005 Dec; 12(6):423-6. PubMed ID: 16414299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted infections among multi-transfused patients in Brazil.
    de Paula EV; Gonçales NS; Xueref S; Addas-Carvalho M; Gilli SC; Angerami RN; Veríssimo MP; Gonçales FL
    J Clin Virol; 2005 Dec; 34 Suppl 2():S27-32. PubMed ID: 16461237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency distribution and risk factors of hepatitis B virus and hepatitis C virus infections among thalassemia patients: a regional study.
    Shah T; Hussain W; Ali N; Sardar S; Ishaq M; Ur Rahman M; Ding L; Qayyum S; Khan I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):248-252. PubMed ID: 30358571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.
    Ramsey SD; Unger JM; Baker LH; Little RF; Loomba R; Hwang JP; Chugh R; Konerman MA; Arnold K; Menter AR; Thomas E; Michels RM; Jorgensen CW; Burton GV; Bhadkamkar NA; Hershman DL
    JAMA Oncol; 2019 Apr; 5(4):497-505. PubMed ID: 30653226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics.
    Amarapurkar DN; Kumar A; Vaidya S; Murti P; Bichile SK; Kalro RH; Desai HG
    Indian J Gastroenterol; 1992 Apr; 11(2):80-1. PubMed ID: 1428037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias.
    al-Mahroos FT; Ebrahim A
    Ann Trop Paediatr; 1995 Jun; 15(2):121-8. PubMed ID: 7677412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for hepatitis B and C in multi-transfused patients in Uruguay.
    López L; López P; Arago A; Rodríguez I; López J; Lima E; Insagaray J; Bentancor N
    J Clin Virol; 2005 Dec; 34 Suppl 2():S69-74. PubMed ID: 16461243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.